We are live on ! Find out more
KITE

Kite Pharma, Inc.
KITE

Delisted

KITE was delisted on the 2nd of October, 2017.

Back to rankings

0 hedge funds and large institutions have $0 invested in Kite Pharma, Inc. in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 241 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 244 → 0 (-244)

100% less funds holding in top 10

Funds holding in top 10: 23 → 0 (-23)

100% less capital invested

Capital invested by funds: $8.87B → $0 (-$8.87B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 241

Holders
–
Holders Change
-244
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-23
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
241
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
CI
Cowen Inc
New York
-$755M
2
BlackRock
BlackRock
New York
-$744M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$736M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$483M
5
WCM
Wildcat Capital Management
New York
-$433M
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
126
Boothbay Fund Management
New York
– -$4.23M -23,517 Closed
PP
127
Paloma Partners
Connecticut
– -$4.17M -23,199 Closed
PG
128
PEAK6 Group
Illinois
– -$4.08M -22,680 Closed
PA
129
Profund Advisors
Maryland
– -$4.07M -22,648 Closed
WRBC
130
W.R. Berkley Corp
Connecticut
– -$4.05M -22,500 Closed
Squarepoint
131
Squarepoint
New York
– -$3.83M -21,317 Closed
Legal & General Group
132
Legal & General Group
United Kingdom
– -$3.82M -21,252 Closed
BF
133
BOK Financial
Oklahoma
– -$3.78M -21,035 Closed
AAM
134
Advisors Asset Management
Colorado
– -$3.73M -20,743 Closed
Walleye Trading
135
Walleye Trading
New York
– -$3.66K -20,344 Closed
OTPPB
136
Ontario Teachers' Pension Plan Board
Ontario, Canada
– -$3.6M -20,000 Closed
CCMH
137
Cornerstone Capital Management Holdings
New York
– -$3.29M -18,303 Closed
TI
138
Telemetry Investments
New York
– -$3.07M -17,067 Closed
DekaBank Deutsche Girozentrale
139
DekaBank Deutsche Girozentrale
Germany
– -$2.13M -16,650 Closed
Capital Fund Management (CFM)
140
Capital Fund Management (CFM)
France
– -$2.86M -15,893 Closed
TAM
141
Tocqueville Asset Management
New York
– -$2.84M -15,780 Closed
SAM
142
Shikiar Asset Management
New York
– -$2.81M -15,600 Closed
OAC
143
OMERS Administration Corp
Ontario, Canada
– -$2.77M -15,400 Closed
EAM
144
Exane Asset Management
France
– -$2.7M -15,000 Closed
DCM
145
Dupont Capital Management
Delaware
– -$2.63M -14,600 Closed
PAM
146
Panagora Asset Management
Massachusetts
– -$2.55M -14,169 Closed
AWCI
147
Alpine Woods Capital Investors
New York
– -$2.52M -14,000 Closed
VIA
148
Vident Investment Advisory
Georgia
– -$2.38M -13,213 Closed
RJA
149
Raymond James & Associates
Florida
– -$2.34M -13,012 Closed
CIA
150
Capital Impact Advisors
Massachusetts
– -$2.32M -12,922 Closed
4 5
6
7 8

KITE Hedge Fund Activity: Q4 2017 in Review

0 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Kite Pharma, Inc. (KITE) for Q4 2017, worth a combined $0 — down 100% from $8.87B a quarter earlier.

Sellers outnumbered buyers: 241 funds closed out of KITE and 0 opened new positions — a net loss of 241 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Cowen Inc, exiting entirely with an estimated $755M sold.

  • 0 institutional investors held Kite Pharma, Inc. (KITE) as of Q4 2017, down from 244 in Q3 2017.
  • Funds reported $0 of Kite Pharma, Inc. stock for Q4 2017, down 100% quarter-over-quarter.
  • 0 funds opened new Kite Pharma, Inc. positions in Q4 2017 and 241 closed out, a net change of -241 holders.
  • The largest Kite Pharma, Inc. seller in Q4 2017 was Cowen Inc, an estimated $755M sold.

Based on aggregated 13F filings for Q4 2017.